| Name | Title | Contact Details |
|---|
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.
T-Base Communications Inc is a Ottawa, ON-based company in the Business Services sector.
Knobias.Com, LLC is a Ridgeland, MS-based company in the Business Services sector.
Coil Tubing Partners is an oil and energy company based in Lafayette, Louisiana, founded in 1998. The company specializes in coil tubing services and provides fluid and nitrogen pumping equipment for the oilfield services sector. With a workforce of approximately 195 to 318 employees, Coil Tubing Partners generates annual revenues estimated between $20 million and $68 million. The company offers specialized well intervention services using continuous length tubing to perform tasks such as drilling out plugs and cleaning out wells. Additionally, it provides equipment for pumping various fluids and nitrogen gas, which are essential for well operations. Coil Tubing Partners serves a diverse range of clients, including major energy companies and oilfield service providers, reflecting its strong presence in the industry. The company is recognized for its operational expertise and commitment to delivering value to its customers.